Ankylosing Spondylitis Treatment

Ankylosing Spondylitis: What It Is and Why the Right Care Matters

Ankylosing spondylitis is a chronic inflammatory arthritis that mainly affects the spine and the sacroiliac joints, which connect the lower spine to the pelvis. It is driven by the immune system rather than by wear and tear, and it typically begins in early adulthood. Treatment aims to control inflammation, reduce pain and stiffness, preserve posture and mobility, and prevent long-term complications such as fusion of the spinal joints.

The condition can be difficult to recognise at first because it often begins gradually. Many people describe months or years of lower back pain, morning stiffness, fatigue, or discomfort that improves with movement but returns after rest. Because symptoms usually start in early adulthood, the pain is often blamed on work, sport, posture or stress, and the real cause goes unexamined. That uncertainty can be frustrating, especially when pain disturbs sleep, work, exercise, travel or family life.

People weighing up specialist care usually carry several questions at once. Do I have the correct diagnosis? Can my pain and stiffness be controlled? Will my spine become permanently stiff or bent forward? Do I need lifelong medication? How can I receive coordinated care if my condition affects my eyes, skin, bowel, hips or heart? These are reasonable questions, and they deserve careful evaluation by physicians who manage inflammatory spine disease regularly.

Care for ankylosing spondylitis is not limited to medication. A structured plan usually combines rheumatology assessment, advanced imaging, laboratory testing, targeted drug therapy, physical therapy, exercise guidance, pain control and monitoring for related conditions. When treatment starts early and is adjusted thoughtfully, many patients remain active, continue working and protect spinal function over time.

At Acibadem, ankylosing spondylitis is approached as a chronic inflammatory condition that requires both medical precision and a long-term partnership. The aim is to understand the individual pattern of disease, identify active inflammation, address complications early, and build a plan that fits the patient’s life — not only the diagnosis.

Dr. Tarek ArafatMDBoard Commentary

Ankylosing spondylitis is best managed by controlling inflammation while actively preserving mobility, posture and physical function. Acıbadem University researchers validated a questionnaire in 93 patients with axial spondyloarthritis that can identify individual barriers and facilitators to physical activity before an exercise program is designed. A separate multicenter study involving 306 patients and an Acıbadem University-affiliated physician found that a history of falls was associated with longer disease duration, more restricted spinal mobility, poorer function, reduced physical performance and hip involvement, supporting the importance of balance, hip assessment and fall prevention in advanced disease. Current guidelines place active physical therapy, stretching, aerobic conditioning and regular exercise alongside medication rather than treating rehabilitation as an optional addition. NSAIDs remain the initial pharmacological treatment for most adults with active axial spondyloarthritis; when disease remains active, TNF or IL-17 inhibitors are generally preferred as the initial biologic options, while JAK inhibitors provide an additional targeted treatment pathway in appropriate patients. The presence of recurrent uveitis, inflammatory bowel disease or psoriasis should influence drug selection and specialist coordination. Diagnosis should similarly be based on the complete clinical picture: current guidance favors pelvic radiography as the initial imaging test in adults and sacroiliac-joint MRI without contrast when radiographs are nondiagnostic, with all imaging interpreted alongside symptoms, examination and inflammatory markers.

Commentary reviewed — September 1, 2026View profile →

Spondylitis, Spondyloarthritis and Ankylosis: The Terms Explained

The vocabulary around this condition causes real confusion, partly because several similar-sounding terms describe overlapping ideas, and partly because the disease has different names in different countries. Understanding the words makes the diagnosis itself easier to follow.

What does spondylitis mean?

Spondylitis means inflammation of the vertebrae, the bones that make up the spine. The word on its own does not name a single disease; it describes what is happening in the spine. Ankylosing spondylitis is the most widely known condition in which this inflammation occurs, but spinal inflammation can also appear in related disorders.

What is spondyloarthritis?

Spondyloarthritis is the name of the wider family of inflammatory diseases to which ankylosing spondylitis belongs. When the spine and sacroiliac joints are the main site of disease, doctors use the term axial spondyloarthritis. In some patients, inflammation and structural change are visible on X-rays — this established form corresponds to classic ankylosing spondylitis. In others, inflammation can be detected earlier on MRI before any permanent change appears; this is called non-radiographic axial spondyloarthritis. The two forms are managed with similar principles, which is why an early diagnosis matters even when X-rays look normal.

What does ankylosis mean?

Ankylosis is the stiffening or fusion of a joint, so that it loses part or all of its normal movement. In this disease, long-standing inflammation can trigger new bone formation across spinal joints and ligaments. Over many years, this can join vertebrae together — the “ankylosing” part of the name. Not every patient reaches this stage, and one central purpose of modern treatment is to reduce the inflammation that drives the process.

Is “ankle spondylitis disease” the same condition?

The phrase ankle spondylitis disease is a common misreading of “ankylosing spondylitis” — the condition is named for ankylosis, not for the ankle. The disease centres on the spine and pelvis rather than the ankle joint. That said, ankles genuinely can be involved: some patients develop peripheral arthritis or inflammation at tendon insertions around the ankle and heel, so ankle pain in a person with inflammatory back pain is worth mentioning to the treating physician.

You may also encounter historical and international names. The condition has long been known as Bekhterev’s disease in parts of Europe, and in Norwegian medical writing it appears as ankyloserende spondylitt. All of these terms describe the same underlying disease.

Ankylosing Spondylitis Symptoms

Ankylosing spondylitis symptoms usually develop slowly, over weeks to months rather than overnight, and they follow a recognisable inflammatory pattern that separates them from ordinary mechanical back pain. Mechanical pain tends to worsen with activity and ease with rest. Inflammatory pain does the opposite.

• Lower back or buttock pain that persists for weeks or months
• Morning stiffness that eases as the day goes on
• Pain that improves with movement or exercise
• Discomfort that worsens after prolonged rest or sitting
• Pain during the second half of the night, sometimes waking the sleeper
• Fatigue that feels out of proportion to daily activity
• Improvement with anti-inflammatory medication

What are the first symptoms of ankylosing spondylitis?

The most common first symptom is a dull, deep pain in the lower back or buttocks, often alternating from side to side, together with stiffness after waking. Many patients describe getting up at night to walk or stretch because movement eases the ache. Others first notice heel pain, tightness around the ribs or chest wall, hip or shoulder discomfort, or reduced flexibility when bending or turning the head. Because these early complaints are easy to attribute to strain or posture, the pattern — stiffness after rest, relief with movement — is often more telling than any single symptom.

Which parts of the body can be affected beyond the spine?

Ankylosing spondylitis is a whole-body condition, not purely a back problem. Some patients develop eye inflammation called uveitis, which can cause eye pain, redness, light sensitivity or blurred vision and is usually assessed promptly by an ophthalmologist. Others have psoriasis of the skin, or inflammatory bowel disease such as Crohn disease. Enthesitis — inflammation where tendons or ligaments attach to bone — commonly affects the heel, the sole of the foot, the pelvis, the ribs or the knees. Peripheral arthritis can involve the hips, knees, ankles and shoulders, with hip involvement being particularly important because it affects walking and independence.

Less commonly, long-standing disease can involve the heart and lungs. Inflammation around the aortic root is a recognised, rare association — related in principle to the spectrum of aortic diseases — and it can occasionally affect the aortic valve, which is why some patients are assessed alongside specialists in heart valve diseases. Stiffness of the chest wall can limit deep breathing, and rare forms of pulmonary disease have been described in advanced cases. These associations are uncommon, but they explain why thorough assessment looks beyond the spine.

What are the triggers for ankylosing spondylitis?

There is no single, proven trigger that starts ankylosing spondylitis; the disease arises from a combination of genetic susceptibility and immune activity that is still being studied. Once the condition is established, many patients notice that flares follow prolonged inactivity, physical or emotional stress, infections, poor sleep or smoking. These observations are individual rather than universal, but they are worth tracking, because recognising personal flare patterns helps patients and physicians plan exercise, rest and treatment adjustments more intelligently.

Causes and Risk Factors

The precise cause of ankylosing spondylitis is not fully understood. What is clear is that the immune system produces sustained inflammation at the sacroiliac joints, the spinal joints and the entheses, and that genetics play a substantial role. The condition often runs in families, and it typically declares itself in late adolescence or early adulthood rather than later in life.

Is ankylosing spondylitis an autoimmune disease?

Ankylosing spondylitis is an immune-mediated disease: the body’s own immune system drives the inflammation. Researchers often describe it as having both autoimmune and autoinflammatory features. Unlike rheumatoid arthritis, it is not defined by a specific circulating autoantibody — it belongs to the so-called seronegative spondyloarthritis group. The strongest known genetic association is with HLA-B27, a marker carried by many, but not all, people with the disease. Carrying HLA-B27 does not mean a person will develop ankylosing spondylitis, and its absence does not exclude the diagnosis.

Recognised risk factors include a family history of spondyloarthritis, the HLA-B27 marker, and the presence of related conditions such as psoriasis, uveitis or inflammatory bowel disease. The disease has historically been diagnosed more often in men, although women are genuinely affected and may be diagnosed later because their symptom pattern can differ. None of these factors alone settles the diagnosis; they shape how carefully persistent inflammatory back pain should be investigated.

How Ankylosing Spondylitis Is Diagnosed

How do doctors diagnose ankylosing spondylitis?

Diagnosis rests on the full clinical picture rather than any single test. A rheumatologist typically reviews the timing and character of the pain, the age at onset, family history, response to anti-inflammatory medication, physical examination findings and any symptoms beyond the spine — eyes, skin, bowel, joints and tendons. This conversation is often the key step, because it distinguishes inflammatory back pain from the far more common mechanical causes.

Blood tests may include inflammatory markers such as C-reactive protein and erythrocyte sedimentation rate, along with HLA-B27 testing when appropriate. It is worth being clear about what these tests can and cannot do. Inflammatory markers can be normal even in active disease. HLA-B27 is associated with a higher risk of ankylosing spondylitis, but it does not prove the diagnosis by itself, and some patients with definite disease are HLA-B27 negative.

Imaging is often essential. X-rays may show changes in the sacroiliac joints or spine in more established disease. MRI can detect active inflammation — including bone marrow oedema — much earlier, particularly in the sacroiliac joints, before any damage is visible on X-ray. Ultrasound can be useful in selected cases to assess peripheral joints or tendon insertion sites, and additional imaging may be used to evaluate hip involvement or spinal complications.

Part of a careful diagnosis is ruling other things out. Disc problems, degenerative arthritis, fibromyalgia, infection, fracture and other rheumatological conditions can all mimic aspects of the disease. Careful interpretation avoids both under-treatment of genuine inflammation and over-treatment of pain that has a different cause.

Who May Need Specialist Ankylosing Spondylitis Care

Specialist rheumatology assessment is most relevant for people with persistent back pain that carries inflammatory features, for patients already diagnosed who are not responding well to treatment, and for individuals who have developed problems in joints or organs beyond the spine. It is also valuable for patients who are unsure whether their diagnosis is correct and want the evidence reviewed in detail.

Typical candidates describe lower back or buttock pain lasting longer than several weeks, morning stiffness, pain that improves with activity and worsens with prolonged rest, or night pain relieved by walking and stretching. Others notice reduced spinal flexibility, difficulty bending, pain in the hips or shoulders, heel pain, rib or chest wall tightness, or persistent fatigue.

Because ankylosing spondylitis can involve the eyes, skin, bowel, tendons and peripheral joints, and because these features change which medications are most suitable, coordinated evaluation matters. A person with recurrent uveitis, psoriasis or bowel inflammation alongside back pain has a different clinical picture — and often a different treatment pathway — than a person with spine-only symptoms.

Conditions and Indications Addressed

Treatment addresses both the spinal disease itself and the broader group of problems that can occur with axial spondyloarthritis. The care plan is adapted to disease stage, symptom pattern, imaging results, laboratory findings and the patient’s daily functional needs.

The most common indication is active inflammatory back pain caused by sacroiliac or spinal inflammation — pain that interferes with sleep, sitting, exercise, work or travel. Some patients have recurrent flares despite medication; others have never received a clear diagnosis and have been treated repeatedly for nonspecific back pain.

Care may also be needed for reduced spinal mobility, posture change, or stiffness that limits routine activities such as driving, walking, dressing, bending or turning the head. When the chest wall is involved, deep breathing can become uncomfortable, and physical therapy to maintain chest expansion becomes an important part of the plan.

Peripheral joint disease is another reason for evaluation. Arthritis of the hips, knees, ankles or shoulders — and especially hip involvement, which strongly affects walking and independence — needs specific attention. Enthesitis can cause heel pain, plantar fascia pain, or tenderness around the pelvis, ribs and knees.

Associated inflammatory conditions are managed in coordination rather than in isolation. Uveitis calls for ophthalmology input. Psoriasis can influence the choice of systemic therapy. Inflammatory bowel disease requires gastroenterology coordination, because some medications help both spinal and bowel inflammation while others are less suitable. Patients already taking a biologic may need reassessment if symptoms persist, infections occur, laboratory results change or the treatment loses effect; others need a structured evaluation before targeted therapy begins, covering vaccination status, infection screening, pregnancy considerations and monitoring requirements.

How Ankylosing Spondylitis Treatment Works

Care begins with a detailed consultation. The physician asks about the timing and character of pain, morning stiffness, night symptoms, response to exercise, medication history, family history, and any symptoms involving the eyes, skin, bowel, joints or tendons. This is not an administrative formality; it is frequently the decisive step in separating inflammatory back pain from mechanical causes.

The physical examination assesses spinal mobility, posture, hip movement, chest expansion, joint swelling, tendon tenderness, neurological function and signs of related inflammatory disease. Baseline measurements of spinal flexibility are often recorded so progress can be tracked over time. Previous imaging, laboratory reports and medication lists are reviewed carefully as part of the assessment.

Diagnostic testing is then tailored to the individual: blood tests for inflammation, blood counts, liver and kidney function, infection markers and genetic markers where relevant; X-ray and MRI of the sacroiliac joints or spine; ultrasound in selected cases. From this, the rheumatology team builds an individualised plan. A typical pathway looks like this:

• Step 1 — Assessment: history, examination, laboratory tests and imaging to confirm the diagnosis and measure disease activity.
• Step 2 — First-line medication: a nonsteroidal anti-inflammatory drug (NSAID) chosen for the individual, with clear guidance on use and monitoring.
• Step 3 — Exercise and physiotherapy: a structured mobility and strengthening programme started early, not left until later.
• Step 4 — Escalation where needed: targeted biologic or other advanced therapy if disease activity remains moderate to severe.
• Step 5 — Monitoring: regular review of symptoms, function, laboratory markers and medication safety, with the plan adjusted as needed.

Nonsteroidal anti-inflammatory drugs, commonly known as NSAIDs, can reduce pain and stiffness for many patients and are usually the first medical step. The specific choice takes account of symptom pattern, stomach and kidney safety, cardiovascular risk and other medical factors, and patients are advised on appropriate use rather than taking medication haphazardly or for prolonged periods without supervision.

If symptoms remain active or MRI and laboratory findings show ongoing inflammation, biologic therapies and other targeted medications that act on specific inflammatory pathways may be considered. The choice depends on the patient’s clinical profile — the presence of uveitis, psoriasis or inflammatory bowel disease, infection history, previous biologic exposure, and practical preferences such as injection schedules or travel patterns. Before these medications start, screening for infections such as tuberculosis and hepatitis is commonly performed, sometimes with input from an infectious diseases team, and vaccination status is reviewed.

Physical therapy is integrated early rather than treated as an afterthought. A therapist familiar with inflammatory spine disease teaches exercises that are safe, realistic and sustainable: spinal extension movements, hip flexibility work, core and back strengthening, posture correction, balance training and breathing exercises. Patients also learn how to exercise during flares and how to avoid the prolonged inactivity that worsens stiffness.

Technology supports the whole pathway. Advanced imaging identifies inflammation, structural change and hip involvement. Standardised disease activity scores help physicians track symptoms, function and inflammatory markers over time. Shared electronic records let rheumatology, radiology, physiotherapy, ophthalmology, gastroenterology, dermatology, orthopaedics and pain medicine review the same clinical information when a case needs several specialties.

Timeframes vary. Many patients can complete the core consultations, laboratory testing and imaging within a focused period, though complex cases may need further specialist input before a final plan is confirmed. Medication response is not immediate for everyone: NSAIDs may help within days for some patients, while the effect of biologic therapy is assessed over weeks to months using symptoms, function, laboratory markers and, when needed, imaging.

Can ankylosing spondylitis be cured?

No treatment currently cures ankylosing spondylitis. Accounts titled “how I cured my ankylosing spondylitis” usually describe periods of low disease activity or remission — a genuine and worthwhile goal, but not the permanent elimination of the underlying condition. Recovery is best understood as control: diagnosis and inflammation assessment, symptom control, mobility restoration, long-term monitoring and flare prevention. A good care plan explains what improvement should look like and how treatment will be adjusted if those goals are not met. Being honest about this matters, because chasing an advertised “cure” can lead patients away from treatments that demonstrably protect function.

Surgery is not the usual treatment. It may be considered in selected patients with severe hip damage, spinal fracture, neurological complications or major deformity — hip replacement being the most common example. The great majority of patients are managed medically with careful follow-up.

Stages and Progression of Ankylosing Spondylitis

Progression varies enormously between individuals. Some people have mild, intermittent symptoms for decades; others develop structural change earlier. Understanding the typical sequence helps patients interpret their imaging reports without assuming the worst.

What are the four stages of ankylosing spondylitis?

There is no single official four-stage classification, but the disease is often described as moving through recognisable phases. First, inflammation of the sacroiliac joints (sacroiliitis) that may only be visible on MRI. Second, structural changes at the sacroiliac joints that become visible on X-ray. Third, new bone formation in the spine — bony bridges called syndesmophytes forming between vertebrae. Fourth, in advanced disease, partial or complete fusion of spinal segments, sometimes described as “bamboo spine” on X-ray. Progression through these phases is not inevitable, and modern treatment aims to interrupt the inflammatory process that drives it.

What is the life expectancy of someone with ankylosing spondylitis?

Most people with ankylosing spondylitis live long, active lives, and the condition itself rarely shortens life directly. The long-term outlook is shaped more by general health factors — cardiovascular fitness, smoking, weight, activity levels — and by how well inflammation is controlled and complications are monitored, than by the diagnosis alone. This is one reason follow-up care addresses the whole person: heart and lung health, bone density, medication safety and physical conditioning all belong in the long-term plan.

Why Acting Early Matters

Early recognition can change the course of care. When inflammation is identified before major structural damage occurs, treatment has a better opportunity to reduce symptoms, maintain flexibility and protect daily function. Delayed diagnosis is common — back pain is widespread, and early X-rays frequently look normal — so persistent inflammatory back pain should not be dismissed, particularly in younger adults or people with uveitis, psoriasis, inflammatory bowel disease or a family history of spondyloarthritis.

Untreated or undertreated inflammation may contribute to progressive stiffness, reduced posture control, hip damage, impaired chest expansion, chronic pain, fatigue and reduced quality of life. In advanced disease, new bone formation can lead to fusion of spinal segments, and a fused spine is both less flexible and more vulnerable to certain fractures after trauma. Not every patient progresses this way, but identifying risk factors and monitoring disease activity are core parts of responsible care.

Delay also has a human cost. Living with unexplained pain can bring anxiety, reduced activity, disturbed sleep and a loss of confidence in one’s own body. A clear diagnosis and a structured plan help people understand what is happening and what can realistically be done. Early care does not mean aggressive treatment for everyone; it means accurate assessment, proportionate intervention and thoughtful follow-up.

Benefits of Ankylosing Spondylitis Treatment

The benefits of treatment are most meaningful when connected to daily life, long-term function and the prevention of complications.

Benefit	What It Means for You
Reduced inflammation	Targeted care can help calm immune-driven inflammation in the spine, sacroiliac joints and related areas.
Less pain and morning stiffness	Many patients experience better sleep, easier movement after waking, and improved comfort during daily activities.
Preserved mobility and posture	Exercise therapy and inflammation control support spinal flexibility, upright posture and chest expansion over time.
Protection of joints beyond the spine	Evaluation can identify hip, shoulder, knee, ankle or tendon involvement and guide treatment before function is significantly affected.
Coordinated care for related conditions	Eye inflammation, psoriasis, bowel disease and other associated problems can be considered when choosing treatment.
Personalised long-term planning	Your plan can be adapted as symptoms, imaging findings, lifestyle, travel needs or medication response change.

Recovery and Treatment Timeline

Recovery varies with disease activity, treatment type and baseline mobility, but most patients can understand the process in practical stages.

Time Period	What Patients Can Expect
Day 1	Initial evaluation may include consultation, physical examination, record review, laboratory tests and planning for imaging or specialist assessments.
First Week	Diagnosis is refined, pain control may begin, and patients often receive exercise guidance, medication instructions and safety recommendations.
First Month	Symptoms, medication tolerance, mobility and laboratory findings are reviewed. Physical therapy habits become an important part of daily care.
First 3 Months	If targeted therapy is started, response is monitored using pain, stiffness, function, inflammatory markers and overall disease activity.
Longer Term	Regular follow-up helps maintain disease control, adjust treatment if needed, monitor medication safety and screen for complications.

What Influences a Good Outcome

Outcomes depend on how early the condition is recognised, how active the inflammation is, whether structural damage has already occurred, and how consistently the plan is followed. A good result is not defined only by an imaging report. It includes reduced pain, improved sleep, better movement, fewer flares, safer medication use, preserved work and social function, and confidence in long-term self-management.

Accurate diagnosis is the first major factor. Some people labelled with ankylosing spondylitis actually have mechanical back pain, degenerative disc disease, fibromyalgia, infection or another inflammatory condition. Others have true axial spondyloarthritis with normal early X-rays. Careful interpretation of symptoms, examination, blood tests and imaging protects against both under-treatment and over-treatment.

Disease activity matters too. Patients with persistently raised inflammatory markers, active MRI inflammation, smoking exposure, hip involvement or early structural change may need closer monitoring. Associated conditions influence the best medication choice: a patient with recurrent uveitis or bowel inflammation may need a different strategy from a patient with spine-only symptoms.

Medication adherence and safety monitoring are essential. Anti-inflammatory drugs and targeted therapies can help, but they must be used appropriately, with attention to stomach, kidney, liver, cardiovascular, infection, pregnancy and vaccination factors. Fever, persistent infections, unusual symptoms or side effects are things the treating physician needs to know about promptly, and regular laboratory checks may be recommended depending on the treatment.

Living Well With Ankylosing Spondylitis

Exercise is one of the strongest practical influences on long-term function. Medication may reduce inflammation, but movement preserves the benefit. The most successful programmes are realistic — a sustainable mix of daily stretching, posture work, strengthening and aerobic conditioning. Swimming, walking, supervised gym programmes, Pilates-based rehabilitation and home routines can all play a role, depending on ability and preference. Consistency beats intensity.

Lifestyle shapes outcomes in measurable ways. Smoking is associated with worse spinal disease and poorer lung and cardiovascular health, so stopping smoking is strongly encouraged. Maintaining a healthy weight reduces load on hips and knees. Good sleep, stress management and attention to mood matter, because chronic inflammation and chronic pain both affect emotional health — and emotional health, in turn, affects how well people keep up their exercise and follow-up.

Practical planning helps too. People who travel frequently benefit from a clear medication plan, documentation for injectable treatments where needed, and an agreed approach to managing flares away from home. Follow-up is not optional in a chronic inflammatory condition: treatment may need adjusting as symptoms change, as new evidence emerges, or as life circumstances evolve. A well-managed patient is not prescribed medication and left alone; they are monitored with a clear plan and supported by the right specialists.

Ankylosing Spondylitis Care at Acibadem

Care for ankylosing spondylitis at Acibadem is led by rheumatology within a broader hospital setting, where radiology, physical therapy and rehabilitation, ophthalmology, dermatology, gastroenterology, orthopaedics and pain medicine can be involved when a case requires them. This structure matters because treatment choices genuinely change when a patient has uveitis, psoriasis, bowel inflammation, hip arthritis, osteoporosis, neurological symptoms or medication-related concerns.

Multidisciplinary review is particularly valuable in complex situations. A patient with persistent pain despite biologic therapy may need reassessment of disease activity, medication response, mechanical spine disease, fibromyalgia or hip involvement. A patient with advanced posture change may need rehabilitation planning and, rarely, a surgical opinion. The aim is to understand the whole clinical situation before changing treatment, rather than switching medications reflexively.

Diagnostic pathways use modern laboratory testing and advanced imaging. MRI helps detect active inflammation in the sacroiliac joints and spine; X-rays show structural change in established disease. Findings are always interpreted in the context of symptoms and examination, because MRI changes alone do not always explain pain, and normal tests do not always exclude early disease. Medication decisions follow established, evidence-based recommendations for axial spondyloarthritis, adapted to each patient’s history, disease severity, prior treatments, infection risks and personal goals — with safety evaluation before any targeted therapy begins, and rehabilitation and lifestyle planning integrated rather than treated as secondary.

Some patients come for a first diagnosis; others for a detailed review of an existing one; others because symptoms have returned after years of stable treatment. Where ongoing care will continue with a physician in the patient’s home country, clear medical documentation and written treatment recommendations help maintain continuity, so that what was learned during the assessment travels home with the patient.

How Care Continues Over Time

Ankylosing spondylitis is a chronic condition, but with timely, well-monitored care many patients reduce pain, maintain movement and protect their quality of life for decades. The most effective plans are individualised, reviewed at sensible intervals, and adjusted as the disease and the patient’s circumstances change — a new job, a pregnancy, a planned relocation, or simply a change in how the condition behaves.

What long-term care looks like in practice is unglamorous and effective: consistent exercise, sensible medication use with the agreed safety checks, attention to the eyes, skin, bowel, heart and lungs when symptoms suggest involvement, and regular reassessment of whether the current plan is still the right one. That steady, structured approach — not any single intervention — is what protects function over a lifetime with this disease.